2020
DOI: 10.1097/aln.0000000000003654
|View full text |Cite
|
Sign up to set email alerts
|

Positive Regulatory Domain I–binding Factor 1 Mediates Peripheral Nerve Injury–induced Nociception in Mice by Repressing Kv4.3 Channel Expression

Abstract: Background The transcriptional repressor positive regulatory domain I–binding factor 1 (PRDM1) is expressed in adult mouse dorsal root ganglion and regulates the formation and function of peripheral sensory neurons. The authors hypothesized that PRDM1 in the dorsal root ganglion may contribute to peripheral nerve injury–induced nociception regulation and that its mechanism may involve Kv4.3 channel transcriptional repression. Methods … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 45 publications
0
2
0
Order By: Relevance
“…A gene was considered to be expressed if it had fragments per kilobase per million greater than one. For a gene to be considered differentially expressed, it had to meet two criteria: a greater than 2.0-fold change in expression level and a p-value < 0.05 [81,82].…”
Section: Rna Sequencing and Analysismentioning
confidence: 99%
“…A gene was considered to be expressed if it had fragments per kilobase per million greater than one. For a gene to be considered differentially expressed, it had to meet two criteria: a greater than 2.0-fold change in expression level and a p-value < 0.05 [81,82].…”
Section: Rna Sequencing and Analysismentioning
confidence: 99%
“…Kv4 channels contribute to IA in the heart ( Niwa et al, 2008 ) and play a key role in shaping neuronal excitability, action potential firing rate, synaptic integration and plasticity ( Jerng et al, 2004a ). Dysregulation of Kv4 channels is associated with heart disease ( Huo et al, 2014 ) as well as with neurological disorders, including epilepsy, Alzheimer’s disease, major depressive disorder, Huntington’s disease, and chronic pain ( Hall et al, 2015 ; Scala et al, 2015 ; Kohling and Wolfart, 2016 ; Zemel et al, 2018 ; Carrillo-Reid et al, 2019 ; Noh et al, 2019 ; Aceto et al, 2020 ; Kanda et al, 2021 ; Kim et al, 2021 ; Wang et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%